Over 1650 Total Lots Up For Auction at Five Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12, PA 05/15

Ten biggest nuclear medicine stories of 2022 (so far)

June 10, 2022
Molecular Imaging
From the June 2022 issue of HealthCare Business News magazine

IBA develops low energy, compact cyclotron for small and medium-sized hospitals
IBA announced in January it had developed a new low energy, compact-sized cyclotron designed to bring radiopharmaceutical production in-house at small and medium-sized hospitals.

Known as Cyclone KEY, the solution is meant to create more accessibility for these practices to this PET imaging technology. The machine has a proton acceleration of up to 9.2 megaelectron volts (MeV) and a footprint of 80m², one of the smallest footprints of all clinical cyclotrons.
stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats
With the solution, hospitals can produce three major radioisotopes: Fluorine-18, Carbon-11 and Ammonia-13. From the three of them, they can produce several others such as 18FDG for cancer diagnostics, which is used in more than 90% of PET exams. Others include Na18F for bone scans, 18F-PSMA for prostate cancer imaging, 13NH3 applied in cardiology imaging, and compounds based on carbon-11 for neurology application and drug development.

The solution made its debut in January at Arab Health 2022 in Dubai, UAE. “Some small and medium-sized hospitals require in-house PET compound production to get their independence for a consistent and reliable supply, but also to optimize their costs. Indeed, when hospitals run more exams (for example, two PET scanners instead of one), investing in their own production facility could make them more profitable,” Bruno Scutnaire, executive vice-president of IBA's RadioPharmaSolutions Division, told HCB News.

Small and medium-sized hospitals usually rely on local radiopharmaceutical suppliers. But some areas lack any suppliers, which is a problem due to the average lifetime of PET compounds being around two hours. Additionally, some suppliers may not offer all compounds needed.

The small footprint allows Cyclone KEY to be easily installed, operated and easy to fit into existing hospitals. It is also designed to be user-friendly and cost-effective. It is meant to help address these challenges, as well as minimize the cost that hospitals would have to pay to set up their own radiopharmaceutical production facilities.

You Must Be Logged In To Post A Comment